DENTSPLY SIRONA Inc.
Close on Oct 19, 2026
- Market cap
- $1.69B
- P/E (TTM)
- –
- Dividend yield
- 7.60%
Earnings
Next report expected Nov 5, 2026, before market open (estimated from past report dates)
| Quarter | Reported | Time | Revenue | EPS (GAAP) | EPS (adjusted) |
|---|---|---|---|---|---|
| Q2 FY2026 Ended Jun 30, 2026 | Aug 7, 2026 | Before market open | $898.00M | $0.18 | $0.52 |
| Q1 FY2026 Ended Mar 31, 2026 | May 5, 2026 | After market close | $880.00M | $-0.05 | $0.27 |
| Q4 FY2025 Ended Dec 31, 2025 | Feb 26, 2026 | After market close | $961.00M | $-0.74 | $0.27 |
| Q3 FY2025 Ended Sep 30, 2025 | Nov 6, 2025 | Before market open | $904.00M | $-2.14 | $0.37 |
| Q2 FY2025 Ended Jun 30, 2025 | Aug 7, 2025 | Before market open | $936.00M | $-0.22 | $0.52 |
| Q1 FY2025 Ended Mar 31, 2025 | May 8, 2025 | Before market open | $879.00M | $0.10 | $0.43 |
| Q4 FY2024 Ended Dec 31, 2024 | Feb 27, 2025 | Before market open | $905.00M | $-2.16 | $0.26 |
| Q3 FY2024 Ended Sep 30, 2024 | Nov 7, 2024 | Before market open | $951.00M | $-2.46 | $0.50 |
| Q2 FY2024 Ended Jun 30, 2024 | Jul 31, 2024 | Before market open | – | – | – |
| Q1 FY2024 Ended Mar 31, 2024 | May 2, 2024 | Before market open | – | – | – |
| Q4 FY2023 Ended Dec 31, 2023 | Feb 29, 2024 | Before market open | – | – | – |
Company guidance
Outlook given with results on Aug 7, 2026, compared with the previous outlook
| Measure | Period | Guidance | vs. prior |
|---|---|---|---|
| adjusted EPSnon-GAAP | 2026 | $1.40 to $1.50 | Maintained |
| net sales | 2026 | $3.50B to $3.60B | Maintained |
Figures and the sentence they come from are taken from the company's earnings release. Hover a measure to read the source sentence.
Press releases
Announcements Dentsply Sirona filed with the SEC
Dentsply Sirona Reports Second Quarter 2026 Results
Results of operations · EX-99.1 to Form 8-K/A
EX-99.1 to Form 8-K
Executive or director change · Regulation FD disclosure · EX-99.1 to Form 8-K
Dentsply Sirona Reports First Quarter 2026 Results
Results of operations · EX-99.1 to Form 8-K
Updated GAAP to Non-GAAP Reconciliations
Results of operations · EX-99.2 to Form 8-K
Dentsply Sirona Reports Fourth Quarter and Full Year 2025 Results, Provides Full Year 2026 Outlook
Results of operations · EX-99.1 to Form 8-K
EX-99.1 to Form 8-K
Executive or director change · Regulation FD disclosure · EX-99.1 to Form 8-K
EX-99.1 to Form 8-K
Regulation FD disclosure · EX-99.1 to Form 8-K
EX-99.1 to Form 8-K
Executive or director change · Regulation FD disclosure · EX-99.1 to Form 8-K
Dentsply Sirona Reports Third Quarter 2025 Results
Results of operations · EX-99.1 to Form 8-K
EX-99.1 to Form 8-K
Regulation FD disclosure · EX-99.1 to Form 8-K
Dentsply Sirona Reports Second Quarter 2025 Results
Results of operations · EX-99.1 to Form 8-K
EX-99.1 to Form 8-K
Results of operations · Executive or director change · Regulation FD disclosure · EX-99.1 to Form 8-K
Dentsply Sirona Prices Offering of $550 million of Junior Subordinated Notes
Other events · EX-99.1 to Form 8-K
EX-99.1 to Form 8-K
Executive or director change · Regulation FD disclosure · EX-99.1 to Form 8-K
Dentsply Sirona Reports First Quarter 2025 Results
Results of operations · Other events · EX-99.1 to Form 8-K
Dentsply Sirona Reports Fourth Quarter and Full Year 2024 Results, Provides Full Year 2025 Outlook
Results of operations · EX-99.1 to Form 8-K
EX-99.1 to Form 8-K
Regulation FD disclosure · EX-99.1 to Form 8-K
EX-99.1 to Form 8-K
Executive or director change · Regulation FD disclosure · EX-99.1 to Form 8-K
J.P. Morgan Healthcare Conference Simon Campion President and Chief Executive Officer January 15, 2025
Regulation FD disclosure · EX-99.1 to Form 8-K
EX-99.2 to Form 8-K
Regulation FD disclosure · EX-99.2 to Form 8-K
Press: Marion Par-Weixlberger Vice President, Public Relations & Corporate Communications +43 676 848414588 [email protected]
Regulation FD disclosure · Other events · EX-99.1 to Form 8-K
Dentsply Sirona Reports Third Quarter 2024 Results
Results of operations · Executive or director change · EX-99.1 to Form 8-K
EX-99.1 to Form 8-K
Results of operations · Other events · EX-99.1 to Form 8-K
Press: Marion Par-Weixlberger Vice President, Public Relations & Corporate Communications +43 676 848414588 [email protected]
Executive or director change · Regulation FD disclosure · EX-99.1 to Form 8-K
Dentsply Sirona Reports Second Quarter 2024 Results and Announces Second Phase of Transformation
Results of operations · Exit or restructuring costs · Executive or director change · Regulation FD disclosure · EX-99.1 to Form 8-K
Dentsply Sirona Reports First Quarter 2024 Results
Results of operations · EX-99.1 to Form 8-K
Press: Marion Par-Weixlberger Vice President, Public Relations & Corporate Communications +43 676 848414588 [email protected]
Executive or director change · Regulation FD disclosure · EX-99.1 to Form 8-K
Dentsply Sirona Reports Fourth Quarter and Full Year 2023 Results, Provides Full Year 2024 Outlook, Raises Dividend
Results of operations · EX-99.1 to Form 8-K
under the symbol XRAY. Visit www.dentsplysirona.com for more information about Dentsply Sirona and its products. Contact Information: Investors: Andrea Daley Vice President, Investor Relations +1-704-805-1293 [email protected]
Results of operations · Regulation FD disclosure · EX-99.1 to Form 8-K
J.P. Morgan Healthcare Conference Simon Campion President and Chief Executive Officer January 10, 2024
Results of operations · Regulation FD disclosure · EX-99.2 to Form 8-K
Marion Par-Weixlberger Vice President, Public Relations & Corporate Communications +43 676 848414588 [email protected]
Regulation FD disclosure · EX-99.1 to Form 8-K
2023 Investor Day November 9, 2023 Charlotte, NC
Regulation FD disclosure · EX-99.2 to Form 8-K
Dentsply Sirona Reports Third Quarter 2023 Results
Results of operations · Executive or director change · Regulation FD disclosure · EX-99.1 to Form 8-K
EX-99.2 to Form 8-K
Results of operations · Executive or director change · Regulation FD disclosure · EX-99.2 to Form 8-K
EX-99.3 to Form 8-K
Results of operations · Executive or director change · Regulation FD disclosure · EX-99.3 to Form 8-K
+1-704-805-1293 [email protected] Press: Marion Par-Weixlberger VP, Corporate Communications and PR +43 676 848414588 [email protected]
Executive or director change · Regulation FD disclosure · EX-99.1 to Form 8-K
Dentsply Sirona Reports Second Quarter 2023 Results
Results of operations · Charter or bylaw amendment · Regulation FD disclosure · Other events · EX-99.1 to Form 8-K
EX-99.2 to Form 8-K
Results of operations · Charter or bylaw amendment · Regulation FD disclosure · Other events · EX-99.2 to Form 8-K
Dentsply Sirona Reports First Quarter 2023 Results
Results of operations · EX-99.1 to Form 8-K
EX-99.1 to Form 8-K
Regulation FD disclosure · Other events · EX-99.1 to Form 8-K